Status:
UNKNOWN
Efficacy of Red Light in the Treatment of Pigmentary Disorders
Lead Sponsor:
University of British Columbia
Conditions:
Melasma
Lichen Planus Pigmentosus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pigmentary disorders such as melasma, lichen planus pigmentosus and vitiligo can significantly affect patients' quality of life. Treatment responses are usually slow and typically have limited efficac...
Detailed Description
This will be a participant and evaluator blinded trial with random allocation of one side of the face or affected area to treatment and the contralateral side as control. Random allocation of the trea...
Eligibility Criteria
Inclusion
- Participants must be 18 years or older.
- Participants should be competent to give fully informed consent by themselves
- Should have received a diagnosis of either melasma, lichen planus pigmentosus or vitiligo either clinically or pathologically and have bilateral facial hyperpigmentation/depigmentation or bilateral similar sized depigmented/hyperpigmented patches or a single patch larger than 25 cm2.
- Participants must stop receiving topical treatments or phototherapy 4 weeks prior to commencing the study
Exclusion
- Known photosensitivity disorder
- Unable to attend follow up appointments or twice weekly treatments
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04308421
Start Date
March 1 2020
End Date
September 1 2020
Last Update
March 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Skin Care Centre, Vancouver General Hospital
Vancouver, British Columbia, Canada, V5Z 4E8